Shows / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology. Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com. Editor's note: Episodes…
Episodes
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
T1D Glycemic Improvement and CRISTAL at ATTD 2024
In this episode, hosts provide insight from automated insulin delivery updates from the 17th annual International Conference on Advanced Technologies &…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesFLOW Trial and Chronic Kidney Disease Updates, with Brendon Neuen, MBBS, PhD
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives hosts are joined by Brendon Neuen, MBBS, PhD, nephrologist and…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDexcom Stelo and CGM Updates, with Jake Leach
Hosts of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives recorded a special edition episode with Jake Leach, chief operating officer of…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tirzepatide and the Future of Incretin Therapies, with Timothy Garvey, MD
W. Timothy Garvey, MD, professor of medicine and director of the Diabetes Research Center at the University of Alabama at Birmingham and the principal…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
SELECT, Semaglutide, & the Future of Incretin Therapies, with A. Michael Lincoff, MD
In this episode, hosts are joined by co-chair of the SELECT steering committee A. Michael Lincoff, MD, to discuss results, potential explanations for…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Understanding MARD, Comparing Popular CGM Sensors
In this episode, the hosts breakdown a pair of recent publications related to better understanding the strengths and limitations of MARD as well as a study…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ATTD 2024 Preview
In the episode, hosts provide insight into sessions to watch, device news they are excited for, what makes ATTD a unique and valuable experience for the…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesTime in Range, CGM Metrics for Predicting Outcomes in Diabetes
The introduction of CGM in 1999 completely shifted the trajectory of care for people with diabetes. Now, new data suggest advanced CGM metrics, such as time in…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesTirzepatide in Type 1 Diabetes, with Viral Shah, MD
In this episode, hosts are joined by Shah for a discussion on his recent proof-of-concept study looking at tirzepatide in type 1 diabetes, the prospect of…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Technology Updates in January 2024
In this episode, hosts discuss recent news and updates in diabetes technology from Abbott, Dexcom, and Medtronic in the first half of January 2024.Episode…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesUpdates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD
In this episode, hosts sit down with Ralph DeFronzo, MD, for a discussion on how advances in management have transformed the diagnosis and management of…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Latest Updates on Diabetes Management in Pregnancy
In this episode, the hosts break down a pair of recent studies published in JAMA examining use of non-insulin agents in the management of diabetes during…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes
Hosts discuss a recent study on baricitinib in type 1 diabetes, how these results compare to other data in this arena, and what all of these studies mean for…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: 2023 Top Episodes Recap
To celebrate the end of 2023, hosts recap the top 10 episodes of the past year and offer perspective on how the news discussed in these episodes has shaped the…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Key Updates in ADA Standards of Care—2024
Hosts discuss what they consider the most significant or relevant updates in the ADA's Standards of Care—2024, with a focus on new recommendations for glycemic…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Technology Updates and Standards of Care—2024
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
SELECT Proves Semaglutide 2.4 mg CV Benefit at AHA 2023
In this episode, hosts take a deep dive into the study’s results, including secondary endpoints, and what it means for the care of patients with overweight or…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tirzepatide (Zepbound) Approved for Chronic Weight Management
In this episode, hosts discuss the FDA's approval of tirzeptiade (Zepbound) as an adjunct to lifestyle modification for the chronic weight management in people…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Automated Insulin Delivery News in October 2023
In this episode, hosts discuss the FDA clearance of the Omnipod 5 App for iPhones and a pair of studies examining use of automated insulin delivery systems.
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
SURMOUNT-3 and SURMOUNT-4 Data
In this episode, hosts discuss the results of SURMOUNT-3 and SURMOUNT-4 as well as how it might help inform use of tirzepatide if approved by the US Food and…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
PROTECT Data and Teplizumab in Newly Diagnosed T1D
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical
In this episode, hosts discuss a pair of topics making headlines in recent weeks: the US Food and Drug Administration’s 510(k) clearance for the Accu-Chek Solo…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Making Sense of Semaglutide in Type 1 Diabetes
In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, including…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Clearance of Tandem Mobi and Welldoc's BlueStar Platform
Hosts discuss their experience interacting with the Tandem Mobi pump from the ADCES 2023 meeting and offer perspective on what the Welldoc clearances mean for…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Addressing Health Disparities with Diabetes Technology, with Etty Vider, PharmD
Hosts are joined by Etty Vider, PharmD, for a nuanced discussion surrounding leveraging diabetes technology to improve care for people with diabetes, including…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
What Medicare Drug Price Negotiations Mean for Diabetes
In this special edition episode, hosts break down what the announcement of the 10 drugs selected for Medicare price negotiations under the Inflation Reduction…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: The Role of Nutrition in Diabetes Management, with Dawn Noe, RDN, LD
In this episode, Isaacs and Bellini sit down with Dawn Noe, RDN, LD, for a discussion surrounding her journey into diabetes care, the importance of…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Implications of SELECT Trial and Brenzavvy on Cost Plus Drugs
In this episode, hosts take time to break down the implications of two, potentially paradigm-shifting news in the announcement of the addition of bexagliflozin…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: ADCES 2023 Recap
In this episode, which is the first of multiple special edition ADCES 2023 episodes, hosts hold an overarching discussion of the meeting itself and major…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: ADA 2023 Recap
After a whirlwind conference packed with special episodes and late-breaking data, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Latest News in Insulin Delivery, with Gary Scheiner, MS
Hosts are joined by Gary Scheiner, MS, of Integrated Diabetes Services, to discuss the latest developments in diabetes technology from the floor of the 83rd…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Embracing Diabetes Tech and Social Media as a Clinician, with David Ahn, MD
David Ahn, MD, joins our hosts for a discussion on overcoming barriers with diabetes technology and offers perspective on his experience leveraging social…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric
Julie Heverly, of the Time in Range Coalition, discusses the history of time in range, offers perspective on its utility as a glucose metric, and provides an…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO
Investigators from the TRANSITION-T2D study join Diabetes Dialogue to discuss the study and implications for care.Video version…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: "Second-Generation" Obesity Medications, with W. Timothy Garvey, MD
W. Timothy Garvey, MD, sits down to discuss the results of SURMOUNT-2, the ongoing revolution of antiobesity medications, and why he is concerned over the…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Improving Implementation of New Technology, with Cari Berget, RN, MPH
Hosts are joined by Cari Berget, RN, MPH, for a deep dive into her efforts to improve the implementation of the latest diabetes technologies in real-world…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Managing & Addressing Mental Health Needs in Diabetes
Often overlooked and unrecognized, the mental health challenges accompanying type 1 diabetes are becoming a focal point of discussion for many in the field…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Reforming Language in Metabolic Disease, with Jane Dickinson, RN, PhD
At ADA 2023, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sat down with ADCES President-Elect Jane Dickinson, RN, PhD, to discuss her work to address…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Diabetic Foot Ulcers and Social Determinants of Health
At ADA 2023, hosts sit down with Gary Rothenberg, DPM, to discuss awareness and management of diabetic foot ulcers as well as how social determinants of health…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: What to Know about the iLet Bionic Pancreas
As a follow-up to an episode earlier this year and the FDA clearances of the technology that forms the iLet Bionic Pancreas, hosts sat down in the MJH Life…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Breaking Down AACE's New Type 2 Diabetes Management Algorithms
In this special edition episode, hosts sit down for an in-depth discussion surrounding the new management algorithms from the AACE and break down how they…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Breaking Down the Medtronic 780G Approval, with Robert Vigersky, MD
In this episode, hosts sit down with Robert Vigersky, MD, chief medical officer of Medtronic Diabetes, for a discussion around the MiniMed 780G, including use…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: SURMOUNT-2 Reaction, Omnipod GO, and Verapamil for T1D
In this episode, hosts offer their reaction to topline data from the SURMOUNT-2 trial examining tirzepatide for weight management in T2D, the FDA's clearance…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: CMS Expansion Ushers in New Age of CGM Access
In this in-studio episode, hosts offer insight and perspective into what the news regarding the CMS expansion of CGM coverage means for people with diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: ATTD 2023 Recap
A recap of the top news and research from the 16th annual meeting for Advanced Technologies and Treatments for Diabetes in Berlin, Germany.
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Practical Updates in Pediatric Diabetes, with Stuart Weinzimer, MD
In this episode, Stuart Weinzimer, MD sits down with hosts for a discussion on his research and experience with diabetes technology, the need to focus on…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology Guidelines and Uptake in Diabetes, with Grazia Aleppo, MD
In this episode, hosts are joined by Grazia Aleppo, MD, to discuss the development of guideline recommendations for diabetes technology as well as her top…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: The Role of Patient Voice in Diabetes Management
In this episode, hosts are joined by Marissa Town, BSN, RN, and Renza Scibilia for a discussion centered around the role of the patient voice in diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Actualizing the Optimal Role of Inhaled Insulin, with Joanne Rinker, MS, RDN
In this episode, hosts are joined by the associate director of Medical Affairs and Medical Education at MannKind for a special edition episode from ATTD 23…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Updates in Diabetes Management from ATTD 23, with Irl Hirsch, MD
In this episode, Irl Hirsch, MD, discusses a study he is conducting examining skin changes associated with insulin pump use in people with type 1 diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Screenings for Hearing Loss in Diabetes, with Joanne Rinker, MS, RDN
In this episode from ATTD 2023, hosts are joined by Joanne Rinker, MS, RDN, who provides perspective on hearing loss in diabetes, including prevalence, the…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Mental Health and PRO Standardization, with Katharine Barnard-Kelly, PhD
In this episode, hosts sit down with Katharine Barnard-Kelly, PhD, at ATTD 2023 to discuss the evolving recognition of the role of psychology in diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: FDA Clearance of Tidepool Loop
In this episode of Diabetes Dialogue, ours hosts discuss the clearance of Tidepool Loop, what is unique about the app’s customizability and compatibility with…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: ADCES DTC 22, with Jennifer Okemah, RD, and Gary Scheiner, MS
In their final episode from the ADCES 2nd Annual Diabetes Technology Conference, our hosts are joined by Gary Scheiner, MS, and Jennifer Okemah, RD, to discuss…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: The Prospect of a Bionic Pancreas, with Steven Russell, MD, PhD
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Steven Russell, MD, PhD, the chief medical officer of…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: December 2022
In the December 2022 episode, Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss recent developments in the field, with a spotlight on the…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: The Psychology of Diabetes Management, with Jill Weissberg-Benchell, PhD
In this episode of Diabetes Dialogue, Jill Weissberg-Benchell, PhD, takes hosts through her journey to becoming a diabetes care and education specialist, the…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Updates in Inpatient Management of Diabetes, with Jane Jeffrie Seley, DNP, MPH
Jane Jeffrie Seley, DNP, MPH, a member of the writing committee for the ADA's Standards of Care in Diabetes—2023, joins the podcast to discuss pertinent…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: What Teplizumab Means for Type 1 Diabetes
Hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, break down what the approval of teplizumab means for type 1 diabetes. During the episode, hosts take a…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Obesity Updates, with Lydia Alexander, MD
In this episode, our hosts are joined by Lydia Alexander, MD, president-elect of the Obesity Medicine Association, to discuss the updates in the landscape of…